You ask for Botox. That is understandable: the name has become shorthand for a whole treatment. But before you go ahead, one simple question is worth asking: which exact product will be used?
Why the name matters
Botox is the name of a specific medicine, while other botulinum toxin type A medicines can be used for facial movement or certain medical conditions. They affect signalling between nerves and muscles, but their labels, doses and authorised uses are not identical. A treatment record should therefore say more than simply “Botox”.
For what a visit involves, when results may appear and aftercare, read our Botox treatment guide. Here, we focus on product names and the questions that help you understand the plan.
Five names found in Serbia
Serbia’s medicines agency, ALIMS, lists Botox, Vistabel, Dysport, Bocouture and Xeomin in its register of marketing authorisations. That does not mean every clinic stocks all five, or that every product is authorised for every aesthetic area. The Serbian product information for the proposed medicine matters.
The units trap
Two quotations can look comparable until you realise they count the units of different brands. Those units are not a shared currency: Serbian product information warns against simply substituting one medicine’s units for another’s. Nor does a price per unit alone tell you the overall cost or likely result.
If you have previously had treatment, bring the product name, area and date to your consultation. Your own response is more useful than somebody else’s dose-conversion chart.
Which lasts the longest?
No honest ranking promises everyone the same duration. Our treatment page gives a general range of three to four months, with individual variation. The area treated, muscle activity and your previous response all matter. A consultation should start with the change you actually want, rather than a claim that one brand is always the longest-lasting.
A conversation before treatment
Rather than “Which brand is best?”, ask “Which medicine do you suggest for me, why, and what can I reasonably expect?” Assessment considers your anatomy, expression, previous treatments, medication and goals. A use outside the product’s authorised indication must be explained clearly and covered in informed consent.
Tell your clinician about previous reactions, neuromuscular conditions, swallowing or breathing difficulties, infection at the proposed injection site, pregnancy or breastfeeding, and any botulinum toxin you have received elsewhere. Depending on the product and area, side effects may include a local reaction, headache or temporary eyelid droop. Seek urgent medical attention if you develop problems speaking, swallowing or breathing after treatment.
Questions patients often ask
Is every product Botox?
No. Botox is one name. Vistabel, Bocouture, Dysport and Xeomin are separately listed medicines in the Serbian register.
Can I request the same number of units as last time?
Not automatically if the product has changed. The plan is made for the specific medicine and your anatomy.
Are all five available at ESTERA?
Registration does not mean the clinic uses every product. Ask for the medicine’s exact name before treatment; its name and batch should be entered in your record.
Next step: let’s discuss your goal
Want your expression to remain yours, with softer lines? Book a consultation at ESTERA. We can assess the area, discuss your expectations and explain the proposed treatment and exact medicine before you decide. A consultation does not commit you to treatment.
Read more about Botox treatment at ESTERA. Current pricing should be checked with the clinic before treatment.
Official sources
ALIMS product records: Botox, Vistabel, Dysport, Bocouture, Xeomin (PIS register, checked 29 September 2026).
Serbian summaries of product characteristics: Vistabel, Bocouture, Botox, Dysport, Xeomin. Documents checked on 29 September 2026; confirm the current summary before treatment.